Compare SSTI & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSTI | VANI |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 81.2M |
| IPO Year | 2017 | 2014 |
| Metric | SSTI | VANI |
|---|---|---|
| Price | $6.59 | $1.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $17.00 | $4.00 |
| AVG Volume (30 Days) | ★ 205.8K | 186.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,749,000.00 | N/A |
| Revenue This Year | $4.97 | N/A |
| Revenue Next Year | $10.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.78 | $0.91 |
| 52 Week High | $19.43 | $1.92 |
| Indicator | SSTI | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 49.10 |
| Support Level | $5.78 | $1.25 |
| Resistance Level | $6.35 | $1.40 |
| Average True Range (ATR) | 0.45 | 0.08 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 59.83 | 64.00 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.